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 Table 1:  Demographic and Pathologic Characteristics Between  
CDRCC and CCRCC 
 CDRCC N (%) 
CCRCC 
N (%) p-value 
Total cases 160 33,252  
 
Demographics 
 
Age   0.44 
     < 50 32 (20) 5,222 (16)  
     51 – 59 36 (23) 7,634 (23)  
     60 – 69  39 (24) 8,606 (26)  
     70 – 79 31 (19) 7,853 (24)  
     80 +  22 (14) 3,937 (12)  
Race   < 0.001 
     White 112 (70) 28,495 (86)  
     Black 36 (23) 2,849 (9)  
     Other 12 (8) 1,759 (5)  
Gender   0.03 
     Male 112 (70) 20,502 (62)  
     Female 48 (30) 12,750 (38)  
Year of Diagnosis   0.44 
     2001 26 (16) 6,287 (19)  
     2002 25 (16) 6,284 (19)  
     2003 40 (25) 6,655 (21)  
     2004 36 (23) 6,899 (21)  
     2005 33 (21) 7,127 (21)  
 
Pathologic Characteristics 
 
Tumor size – median (range)    
Stage   < 0.001 
     T1a 42 (26) 11,008 (33)  
     T1b 17 (11) 6,669 (20)  
     T2 16 (10) 4,052 (12)  
     T3/4 53 (33) 5,952 (18)  
     No Tstage 32 (20) 5,571 (17)  
SEER stage   < 0.001 
     Localized 68 (43) 20,803 (63)  
     Regional 45 (28) 5,330 (16)  
     Distant 44 (28) 5,705 (17)  
     Unstaged 3 (2) 1,414 (4)  
Nodal status   <0.001 
     N0 13 (8) 3,523 (10.6)  
     N1 24 (15) 765 (2)  
     Nx 123 (77) 28,964 (87)  
Metastatic 44 (28) 5,705 (17) 0.001 
Grade    < 0.001 
     Well differentiated 10 (10) 3,610 (18)  
     Moderately differentiated 20 (20) 10,612 (52)  
     Poorly/undifferentiated 70 (70) 6,384 (31)  
Surgery 135 (84) 25,969 (78) 0.06 
 
 
 
 
 
 
Table 2:  Disease Specific Survival Multivariate Analysis * 
 CCRCC CDRCC  
 HR 95% CI HR ^ 95% CI 
All Patients 1.00 referent 2.42 1.72 – 3.39 
     
Surgery patients only 1.00 referent 2.72  1.94 – 3.84 
     
≤T3a and non-metastatic 1.00 referent 2.50 1.81 – 3.45 
     
Only high-grade CCRCC 1.00 referent 2.15 1.42 – 3.24 
* Adjusted for age, race, gender, year of diagnosis, registry, stage, grade, surgery, tumor size 
^ p < 0.001 
 
 
 
 
Table 3:  Comparison of largest series on Collecting Duct Carcinoma 
 American Series 
Present study 
Japanese Series 
Tokuda, et al.  
European Series 
Karakiewicz, et al. 
Cases 160 81 41 
    
Age (median) 62 58 61 
Male (%) 70 72 76 
African American (%) 23 not provided not provided 
T3 or greater (%) 38 57 81 
Node positive (%) 15 33 49 
Distant metastasis (%) 28 32 20 
High grade (%) 70 99 78 
Surgical management (%) * 84 99 100 
1-yr DSS 70 69 86 
3-yr DSS 58 45 68 ^ 
HR for DSS compared to CCRCC 2.4 not provided 1.1 
* High grade for Japan/European series is Furman Grade 3 or 4; For present series, high grade includes 
SEER grades poorly and undifferentiated. 
^ estimated from Kaplan Meier curve 
 
 
